Wedbush lowered the firm’s price target on Petco to $6 from $9 and keeps an Outperform rating on the shares. Petco reported Q2 results that beat sales and EBITDA expectations, but the 2H sales and margin outlook was negative, calling for continued discretionary demand pressure, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on WOOF:
- Petco price target lowered to $7 from $11 at Wells Fargo
- Petco price target lowered to $8 from $11 at Baird
- Petco Healthcare (NASDAQ: WOOF) Stumbles after Q2 Earnings Drop 62.5%, Future Projections Disappoint
- Petco falls 8% to $6.00 after cutting FY23 EPS guidance
- Petco Health + Wellness Company, Inc. Reports Second Quarter Earnings